Assessment of Procedure Related Anxiety and Depression in Oncologic Patients before F-18 FDG PET-CT Imaging
- *Corresponding Author:
- Umut Elboga
Gaziantep University, School of Medicine
Department of Nuclear Medicine, Gaziantep, Turkey
Tel: +90-342-360 60 60
Fax: +90-342-360 39 28
E-mail: [email protected]
Received Date: October 14, 2014; Accepted Date: November 25, 2014; Published Date: December 03, 2014
Citation: Elboga U, Elboga G, Can C, Sahin E, Karaoglan H, et al. (2015) Assessment of Procedure Related Anxiety and Depression in Oncologic Patients before F-18 FDG PET-CT Imaging. J Psychiatry 18:215. doi: 10.4172/Psychiatry .1000215
Copyright: © 2015, Umut Elboga, et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: The aim of this study was to study objectively the level of anxiety and depression in patients undergoing positron emission tomography-computed tomography (PET-CT).One hundred and forty four oncologic out-patients (76 male, 68 female) were included in this study. Methods: All patients were referred to Nuclear Medicine Department for Fluorine-18 fluorodeoxyglucose (F-18 FDG) PET-CT imaging for the assessment of their malignant or possibly malignant diseases. The Hospital Anxiety Depression Scale and the State and Trait Anxiety Inventory I and II were used to evaluate the anxiety and depression levels in these patients. Results: The mean anxiety and depression scores of The Hospital Anxiety Depression Scale prior to F-18 FDG PET-CT were 9.2 ( ± 3.8) and 6.6 ( ± 3.4), respectively. The mean state and trait anxiety scores of the State and Trait Anxiety Inventory I and II prior to F-18 FDG PET-CT were 40.4 (± 8.5) and 46.62 ± 7.8, respectively. The Hospital Anxiety Depression Scale and the State and Trait Anxiety Inventory I and II anxiety scores were found to be significantly higher in female patients, smokers and in patients with higher stage disease. Conclusion: Our results suggest that F-18 FDG PET-CT imaging may at least contribute to patient’s baseline anxiety which is already generated by being an oncology patient, and thus nuclear medicine physicians should handle the patients with extra care to minimize this affect.